IL-2
2007-0635
Phase 1 small_molecule completed
Quick answer
IL-2 for Lymphoma is a Phase 1 program (small_molecule) at Alaunos Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Alaunos Therapeutics
- Indication
- Lymphoma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed